特发性肺纤维化与慢阻肺的肺康复:倾向匹配真实世界研究
这项真实世界研究通过倾向评分匹配,将163例特发性肺纤维化(IPF)患者与163例慢阻肺(COPD)患者1:1匹配,比较同一门诊监督下肺康复项目的完成率与反应。在IPF中,肺康复未完成(HR 5.62,95%CI 2.24-14.08)和未反应(HR 3.91,95%CI 1.54-9.93)均独立关联1年全因死亡率升高。
要点
- 两组运动反应改善无显著差异(ISWT变化均值2米,95%CI -18至22米)。
- IPF中肺康复未完成和未反应独立关联1年全因死亡率升高。
核心结论
- IPF患者与匹配的COPD患者肺康复完成率和反应程度相似。
- 在IPF中,肺康复未完成和未反应与1年全因死亡率升高独立相关。
研究设计与样本
- 真实世界研究,采用倾向评分匹配,将163例IPF患者与163例COPD患者1:1匹配。
- 两组均接受同一监督下门诊肺康复项目,比较完成率和反应。
- IPF队列记录肺康复出院后1年生存状态,采用Cox比例风险回归分析。
主要发现
- 两组运动反应改善相似,ISWT变化均值组间差异为2米(95%CI -18至22米)。
- IPF中肺康复未完成与1年全因死亡率升高独立相关(HR 5.62,95%CI 2.24-14.08)。
- IPF中肺康复未反应与1年全因死亡率升高独立相关(HR 3.91,95%CI 1.54-9.93)。
临床怎么用
- IPF患者可考虑转介肺康复,其完成率和反应与COPD患者相当。
- 应关注IPF患者肺康复的完成情况,未完成或未反应者可能提示死亡风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The adherence to and clinical efficacy of pulmonary rehabilitation in idiopathic pulmonary fibrosis (IPF), particularly in comparison with COPD, remains uncertain. The objectives of this real-world study were to compare the responses of patients with IPF with a matched group of patients with COPD undergoing the same supervised, outpatient pulmonary rehabilitation program and to determine whether pulmonary rehabilitation is associated with survival in IPF. RESEARCH QUESTION: Do people with IPF improve to the same extent with pulmonary rehabilitation as a matched group of individuals with COPD, and are noncompletion of or nonresponse to pulmonary rehabilitation, or both, associated with 1-year all-cause mortality in IPF? STUDY DESIGN AND METHODS: Using propensity score matching, 163 patients with IPF were matched 1:1 with a control group of 163 patients with COPD referred for pulmonary rehabilitation. We compared between-group pulmonary rehabilitation completion rates and response. Survival status in the IPF cohort was recorded over 1 year after pulmonary rehabilitation discharge. Cox proportional hazards regression explored the association between pulmonary rehabilitation status and all-cause mortality. RESULTS: Similar pulmonary rehabilitation completion rates (IPF, 69%; COPD, 63%; P = .24) and improvements in exercise response were observed in both groups with no significant mean between-group differences in incremental shuttle walk test (ISWT) change (mean, 2 m [95% CI, -18 to 22 m]). Pulmonary rehabilitation noncompletion (hazard ratio [HR], 5.62 [95% CI, 2.24-14.08]) and nonresponse (HR, 3.91 [95% CI, 1.54-9.93]) were associated independently with increased 1-year all-cause mortality in IPF. INTERPRETATION: This real-word study demonstrated that patients with IPF have similar completion rates and magnitude of response to pulmonary rehabilitation compared with a matched group of patients with COPD. In IPF, noncompletion of and nonresponse to pulmonary rehabilitation were associated with increased all-cause mortality. These data reinforce the benefits of pulmonary rehabilitation in patients with IPF.
引用
- Nolan CM, Polgar O, Schofield SJ, et al. Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study. Chest. 2021. PMID: 34699771. doi:10.1016/j.chest.2021.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。